Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, et al. Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus
letrozole versus placebo plus letrozole in hormone receptor-positive,
HER2-negative advanced breast cancer. Ann Oncol 2019;30:1842.
PMID: 31987093